Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma

Annals of Hematology

Volumn 79, Issue 10, 2000, Pages 574-577

  Sezer, O ^a   Niemoller K ^a   Eucker, J ^a   Jakob, C ^a   Kaufmann, O ^a   Zavrski, I ^a   Dietel, M ^a   Possinger, K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Angiogenesis; Bone marrow; Microvessel density; Multiple myeloma

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CD34 ANTIGEN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033787241     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000236     Document Type: Article

References (21)

1. Vascular enumeration as a significant prognosticator for invasive breast carcinoma
2. C-reactive protein and β2-microglobulin produce a simple and powerful myeloma staging system
3. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma
4. Prognostic relevance of micro-vessel density in cancer of the urinary bladder
5. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
6. Angiogenesis in cancer, vascular, rheumatoid and other disease
7. New perspectives in clinical oncology from angiogenesis research
8. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease
9. Vascular enumeration as a prognosticator for colorectal carcinoma
10. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas
11. Evidence of increased angiogenesis in patients with acute myeloid leukemia
12. Angiogenesis in newly diagnosed multiple myeloma: Poor prognosis with increased microvessel density in bone marrow biopsies
13. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
14. Spectrum of tumour angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
15. Angiogenesis in myelodysplastic syndromes
16. Bone marrow angiogenesis in complete responders after stem cell transplantation for multiple myeloma
17. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
18. Antitumor activity of thalidomide in refractory multiple myeloma
19. Bone marrow angiogenesis and progression in multiple myeloma
20. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2-secretion parallel progression of human multiple myeloma
21. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma